Mithra raises 20m through private placement
Women’s health specialist Mithra Pharmaceuticals SA has entered into a definitive agreement to raise 20m in gross proceeds via a private placement of 10 million new ordinary shares with Armistice […]
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1247 entries already.
Entries by Thomas Gabrielczyk
Synbio experts develop cells that hear
/in News/by Thomas GabrielczykETH Zurich researchers have developed a gene switch that triggers insulin release in designer cells by playing music.
Researchers decipher mystery of oil-eating microbes
/in News/by Thomas GabrielczykOil-eating bacteria form dendritic biofilms that reshape oil droplets to speed up the rate of consumption
Valneva announces extension of existing loan agreement
/in News/by Thomas GabrielczykFrench vaccine maker Valneva SE will double the amount of a US$100m debt financing granted by Deerfield Management Company and OrbiMed.
Spexis AG bags money for pivotal Phase III trial
/in News/by Thomas GabrielczykSwiss Spexis AG has announced a US$2.5m capital commitment to fund a two-part pivotal Phase III study to get market approval for its inhaled cystic fibrosis antibiotic colistimethate sodium.
Novo Nordisk takes over Inversago Pharma Inc.
/in News/by Thomas GabrielczykWith a US$1bn acquisition of Canadian Inversago Pharma, Novo Nordisk A/S fiights to maintain its dominant position in the booming weight loss drug market.
Promising viral gene therapy for genetic kidney disease
/in News/by Thomas GabrielczykBritish researchers have proven that a new gene can prevent progression of hereditary kidney damage in mice.
Alianza Team invests in microbial oil maker Clean Food Group
/in News/by Thomas GabrielczykLipid, nutrition and frozen bakery specialist Allianza Team puts £900,500 into pre-Series A financing of microbial palm oil producer Clean Food Group Ltd.
More marine plastics than expected
/in News/by Thomas GabrielczykA Dutch-German team of researchers has found out that the amount of not degradable plastics is lower than estimated but that they persist for longer than previously assumed.
Sygnature Discovery Ltd acquires leading Canadian CRO
/in News/by Thomas GabrielczykBritish drug discovery specialist Sygnature Discovery Ltd has taken over Canadian NuChem Sciences Inc., one of North Americas largest discovery CROs